Skip to main content
. 2021 May 20;12(5):980–989. doi: 10.1177/21925682211013011

Table 1.

Review Inclusion/Exclusion Criteria.

Review criteria Inclusion Exclusion
Patient population Age ≥18 years old
Indicated pathologies:
  • Adjacent segment disease

  • Degenerative disc disorders

  • Degenerative scoliosis

  • Low-grade spondylolisthesis

  • Stenosis

Group size ≥5 subjects
Age <18 Years Old
Out-of-scope pathologies:
  • Revision Surgery

  • Tumors

  • Trauma

  • Infection

  • High-grade spondylolisthesis

Group size <5 subjects
Intervention DLIF, LLIF, LIF, OLIF, or XLIF ± (stand-alone, PSF, and/or open decompression) ALIF, AxiaLIF, PLIF, TLIF
Outcomes Reported PROMs (VAS, ODI, SF-12/36), cross-sectional areas, vertebral angles, complications, revisions Unreported outcomes
Level of evidence I/II—RCT
III—non-random trials
IV—Case-Control/Cohort
Case reports
Reviews
Publication types English language
Peer reviewed journal
Letters & abstracts
Duplicate patient population studies
Feasibility studies
Radiologic diagnostic studies
Cadaveric studies
In Vitro studies
Non-Human studies
Non-English studies

Abbreviations: ALIF, anterior lumbar interbody fusion; AxiaLIF, axial interbody fusion (Baxano Surgical, Raleigh, NC, USA); DLIF, direct lateral interbody fusion (Medtronic Sofamor Danek, Memphis, TN, USA); LIF, lateral interbody fusion; LLIF, lateral lumbar interbody fusion; ODI, Oswestry disability index; OLIF, oblique lumbar interbody fusion (Medtronic Sofamor Danek, Memphis, TN, USA); PLIF, posterior lumbar interbody fusion; PLF, posterior lumbar fusion; PROMs, patient reported outcomes measurements; SF-12, short form-12; SF-36, short form-36; TLIF, transforaminal lumbar interbody fusion; VAS, visual analog scale; XLIF, extreme lateral interbody fusion (NuVasive, San Diego, CA, USA).